Join the CDISC leadership team to learn about the next phase of the 360i Initiative.
CDISC 360i is transforming clinical research by digitizing study design through analysis, making metadata interoperable across the entire study lifecycle. With reusable standards and end-to-end automation, 360i reduces manual tasks, increases data quality, enables AI, ensures traceability and consistency, and empowers the industry to deliver clinical trial results faster, more efficiently, and at a lower cost — accelerating the delivery of new therapies to patients.
In this webinar, CDISC will share details on the next steps in the 360i Initiative, including:
- Digital Transformation needs, stakeholders, and opportunities
- Art of the Possible: vision of how connected standards and digital protocols can drive automated study build and workflows
- Highlights of 360i Phase 1 achievements and findings
- Overview of what’s new in 360i Phase 2, including Analysis Concepts, Digital Data Transfer Agreements, and enhanced automation capabilities that will build on Phase 1 findings to generate analysis artifacts.
- Call For Action: opportunities to contribute and collaborate
Join the conversation to see what’s coming next in 360i and how you can help shape the future of digitally-enabled, standards-based clinical research.
Speakers
- Chris Decker, CEO and President, CDISC
- Peter Van Reusel, Chief Standards Officer, CDISC
- Julie Smiley, Chief Information Officer, CDISC
Language: English